Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Peritoneal Metastases in Solid Organ Graft Recipients: First Experience.
CONCLUSIONS PIPAC can induce objective regression of PM in solid organ transplant recipients without inducing organ toxicity or interfering with immunosuppressive therapy.
PMID: 30643112 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Horvath P, Yurttas C, Struller F, Bösmüller H, Lauer UM, Nadalin S, Königsrainer A, Reymond MA Tags: Ann Transplant Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Eloxatin | Kidney Transplant | Kidney Transplantation | Liver | Liver Transplant | Pancreas | Pancreatic Cancer | Peritoneal Cancer | Toxicology | Transplant Surgery | Transplants | Urology & Nephrology